EU External Trade - Medicaments (excluding goods of heading|3002, 3005|or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale, Other, containing antimalarial active principles described in Subheading Note 2|to this Chapter

Extra-EU sourcing of Medicaments (excluding goods of heading|3002, 3005|or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale, Other, containing antimalarial active principles described in Subheading Note 2|to this Chapter is highly concentrated. 🇨🇦 Canada captures 63.9% of imports (€19.4M), followed by 🇮🇳 India (13.7%). With an HHI of 4417, this Concentrated market exposes the EU to supply dependency risks.

The EU exports Medicaments (excluding goods of heading|3002, 3005|or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale, Other, containing antimalarial active principles described in Subheading Note 2|to this Chapter to 6 extra-EU markets, reflecting solid diversification. 🇧🇷 Brazil remains the largest client (21.6%, €13.2M), followed by 🇧🇷 Brazil, 🇬🇧 United Kingdom, 🇨🇦 Canada.

Within the EU, 🇮🇪 Ireland concentrates 56.6% of Medicaments (excluding goods of heading|3002, 3005|or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale, Other, containing antimalarial active principles described in Subheading Note 2|to this Chapter imports, well ahead of 🇫🇷 France (18.5%). The top importing member states are 🇮🇪 Ireland, 🇫🇷 France, 🇧🇪 Belgium.

The year 2025 marked a turning point: both imports and exports were surging, shifting by 310.7% and 50.3% respectively.